Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial

BACKGROUND: Gambian infants frequently acquire Streptococcus pneumoniae soon after birth. We investigated the indirect effect of 7-valent pneumococcal conjugate vaccine (PCV-7) on pneumococcal acquisition in newborn Gambian babies. METHODS: Twenty-one villages were randomised to receive PCV-7 to all...

Bibliográfalaš dieđut
Váldodahkkit:	Egere, U, Townend, J, Roca, A, Akinsanya, A, Bojang, A, Nsekpong, D, Greenwood, B, Adegbola, R, Hill, P
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Public Library of Science 2012

Geahča maid

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial.
Dahkki: Uzochukwu Egere, et al.
Almmustuhtton: (2012-01-01)

Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial.
Dahkki: Roca, A, et al.
Almmustuhtton: (2011)

Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial.
Dahkki: Anna Roca, et al.
Almmustuhtton: (2011-10-01)

Seasonality of Pneumococcal Nasopharyngeal Carriage in Rural Gambia Determined within the Context of a Cluster Randomized Pneumococcal Vaccine Trial.
Dahkki: Abdoulie Bojang, et al.
Almmustuhtton: (2015-01-01)

Pneumococcal antibody concentrations of subjects in communities fully or partially vaccinated with a seven-valent pneumococcal conjugate vaccine.
Dahkki: Martin O C Ota, et al.
Almmustuhtton: (2012-01-01)

The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule.
Dahkki: Ota, M, et al.
Almmustuhtton: (2011)

Temporal changes in nasopharyngeal carriage of Streptococcus pneumoniae serotype 1 genotypes in healthy Gambians before and after the 7-valent pneumococcal conjugate vaccine
Dahkki: Chinelo Ebruke, et al.
Almmustuhtton: (2015-04-01)

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
Dahkki: Aishatu L. Adamu, et al.
Almmustuhtton: (2023-05-01)

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
Dahkki: Adamu, AL, et al.
Almmustuhtton: (2023)

Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly.
Dahkki: Irina Kislaya, et al.
Almmustuhtton: (2019-01-01)

Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population
Dahkki: Deirdre A. Collins, et al.
Almmustuhtton: (2017-09-01)

Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine.
Dahkki: Adebayo K Akinsola, et al.
Almmustuhtton: (2012-01-01)

Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.
Dahkki: Jo Southern, et al.
Almmustuhtton: (2018-01-01)

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys
Dahkki: Eileen M Dunne, PhD, et al.
Almmustuhtton: (2018-12-01)

Radiographically confirmed pneumonia in Malawian children and associated pneumococcal carriage after introduction of the 13-valent pneumococcal conjugate vaccine
Dahkki: Grace Mzumara, et al.
Almmustuhtton: (2024-10-01)

Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study
Dahkki: Hammitt, LL, et al.
Almmustuhtton: (2019)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
Dahkki: Anna M.M. van Deursen, et al.
Almmustuhtton: (2012-11-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
Dahkki: V. K. Tatochenko, et al.
Almmustuhtton: (2012-03-01)

Nasopharyngeal pneumococcal carriage in healthy Turkish children after 13-valent conjugated pneumococcal vaccine implementation in the national immunization program
Dahkki: Saliha Kanık Yüksek, et al.
Almmustuhtton: (2020-02-01)

Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
Dahkki: Stubbs Liz, et al.
Almmustuhtton: (2009-08-01)

A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccine.
Dahkki: Hamaluba, M, et al.
Almmustuhtton: (2015)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
Dahkki: Edmunds W John, et al.
Almmustuhtton: (2010-04-01)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
Dahkki: Kristiana Alexandrova Nikolova, et al.
Almmustuhtton: (2021-10-01)

13-valent pneumococcal conjugate vaccine in Africa
Dahkki: Robert Cohen, et al.
Almmustuhtton: (2017-03-01)

Indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with acute respiratory infection despite heterogeneous vaccine coverage: an observational study in Lao People's Democratic Republic
Dahkki: Chan, J, et al.
Almmustuhtton: (2021)

Pneumococcal conjugate 7-valent vacciPNEUMOCOCCAL CONJUGATE 7-VALENT VACCINE IN CHILDREN. REGIONAL EXPERIENCEne in children. Regional experience
Dahkki: N. L. Chernaya, et al.
Almmustuhtton: (2012-02-01)

Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey
Dahkki: J. P. Sevilla, et al.
Almmustuhtton: (2020-08-01)

Economic evaluation of pneumococcal conjugate vaccination in The Gambia
Dahkki: Kim Sun-Young, et al.
Almmustuhtton: (2010-09-01)

Indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with acute respiratory infection despite heterogeneous vaccine coverage: an observational study in Lao People’s Democratic Republic
Dahkki: Paul N Newton, et al.
Almmustuhtton: (2021-06-01)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
Dahkki: James T. Peterson, et al.
Almmustuhtton: (2019-03-01)

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
Dahkki: Ralf Rene Reinert, et al.
Almmustuhtton: (2012-06-01)

Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan.
Dahkki: Muhammad Imran Nisar, et al.
Almmustuhtton: (2022-01-01)

Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan
Dahkki: Muhammad Imran Nisar, et al.
Almmustuhtton: (2022-01-01)

Effect of different schedules of ten-valent pneumococcal conjugate vaccine on pneumococcal carriage in Vietnamese infants: results from a randomised controlled trialResearch in context
Dahkki: Heidi Smith-Vaughan, et al.
Almmustuhtton: (2023-03-01)

Pneumococcal carriage in young children one year after introduction of the 13-valent conjugate vaccine in Italy.
Dahkki: Romina Camilli, et al.
Almmustuhtton: (2013-01-01)

Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children
Dahkki: Johan Emdal Navne, et al.
Almmustuhtton: (2017-01-01)

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
Dahkki: George Gourzoulidis, et al.
Almmustuhtton: (2023-09-01)

Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine.
Dahkki: Carina Valente, et al.
Almmustuhtton: (2012-01-01)

Pneumococcal serotypes causing pneumonia in the 13 valent pneumococcal conjugate vaccine era in Australian children
Dahkki: R. Strachan, et al.
Almmustuhtton: (2020-12-01)

RECOMMENDATION ON THE 7–VALENT PNEUMOCOCCAL CONJUGATED VACCINE AMONG CHILDREN
Dahkki: M.V. Fedoseenko, et al.
Almmustuhtton: (2009-06-01)